Skip to main content
Log in

Hyperthermia induced by m-CPP in the rat and its modification by antidepressant treatments

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Administration of the serotonin agonist m-chlorophenylpiperazine to rats produced a dose-related hyperthermia. Pretreatment with the serotonin receptor antagonist metergoline totally abolished this response, whereas similar treatment with haloperidol, phenoxybenzamine, naloxone, clonidine, pindolol, propranolol, methiotepin, and ritanserin was ineffective. In studies investigating the modification of the response by antidepressant treatments both acute (3 day) and chronic (22 day) administration of the MAO inhibitor clorgyline, as well as the tricyclics clomipramine and imipramine, attenuated the hyperthermic response to m-CPP. These findings are discussed with regard to the specificity of m-CPP-induced hyperthermia and its subsequent modification by antidepressant treatments, in order to evaluate this model's use as a probe for assessment of the serotonergic system.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Aloi JA, Insel TR, Mueller EA, Murphy DL (1984) Neuroendocrine and behavioral effects of m-chlorophenylpiperazine administration in rhesus monkeys. Life Sci 34:1325–1331

    Google Scholar 

  • Aulakh CS, Cohen RM, Hill JL, Murphy DL, Zohar J (1987) Long term imipramine treatment enhances locomotor and food intake suppressant effects of m-chlorophenylpiperazine in rats. Br J Pharmacol 81:747–752

    Google Scholar 

  • Bagdy G, Szemeredi K, Zukowska-Grojec Z, Hill J, Murphy DL (1987) m-Chlorophenylpiperazine increases blood pressure and heart rate in pithed and conscious rats. Life Sci 41:775–782

    Google Scholar 

  • Brazenor RW, Augus JA (1982) Actions of serotonin antagonists on dog coronary artery. Eur J Pharmacol 81:569–576

    Google Scholar 

  • Caccia S, Ballabio M, Samanin R (1981) (−)-m-Chlorophenylpiperazine, a central 5-hydroxytryptamine agonist, is a metabolite of trazodone. J Pharm Pharmacol 33:477–478

    Google Scholar 

  • Caccia S, Fong MH, Garattinis V, Zanini MG (1982) Plasma concentrations of trazodone and 1-(3-chlorophenyl)piperazine in man after a single oral dose of trazodone. J Pharm Pharmacol 34:605–606

    Google Scholar 

  • Charney DS, Menkes DB, Heninger GR (1981) Receptor sensitivity and the mechanism of action of antidepressant treatment: implications for the etiology and treatment of depression. Arch Gen Psychiatry 88:1160–1180

    Google Scholar 

  • Cohen ML, Fuller RW (1983) Antagonism of vascular serotonin receptors by m-chlorophenylpiperazine and m-trifluoromethylphenylpiperazine. Life Sci 32:711–718

    Google Scholar 

  • Cohen RM, Aulakh CS, Murphy DL (1983) Long-term clorgyline treatment antagonizes the eating and motor function responses to m-chlorophenylpiperazine. Eur J Pharmacol 94:175–179

    Google Scholar 

  • Colpaert FC, Leysen JE (1981) Characterization of in vivo agonist and antagonist activity of purported 5-hydroxytryptamine antagonists and of R 47 465, and LSD antagonist. In: Abstracts of the Eighth International Congress of Pharmacology, IU-PHAR, Tokyo, Japan, p 595

  • Conn PJ, Sanders-Bush E (1987) Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT2 and 5-HT1C) receptors. J Pharmacol Exp Ther 552–557

  • Fuller RW, Snoddy HD, Mason NR, Owen JE (1981) Disposition and pharmacological effects of m-chlorophenylpiperazine in rats. Neuropharmacology 20:155–162

    Google Scholar 

  • Fuxe K, Agnati L, Everitt B (1975) Effects of methergoline on central monoamine neurones. Evidence for a selective blockade of central 5-HT receptors. Neurosci Lett 1:283–290

    Google Scholar 

  • Fuxe K, Ogren SO, Agnati LF, Calza L (1982) Evidence for stabilization of cortical 5-HT neurotransmission by chronic treatment with antidepressant drugs: induction of a high and low affinity component in 3H-5-HT binding sites. Acta Physiol Scand 114:477–480

    Google Scholar 

  • Fuxe K, Ogren S-O, Agnati LF, Benfenati F, Fredholm B, Andersson K, Zini I, Eneroth P (1983) Chronic antidepressant treatment and central 5-HT synapses. Neuropharmacology 22:389–400

    Google Scholar 

  • Goodwin GM, Green AR (1985) A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors. Br J Pharmacol 84:743–753

    Google Scholar 

  • Goodwin GM, DeSouza RJ, Green AR, Heal DJ (1987) The pharmacology of the behavioural and hypothermic responses of rats to 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). Psychopharmacology 91:506–511

    Google Scholar 

  • Gothert M (1982) Modulation of serotonin release into the brain via presynaptic receptors. TIPS 3:437–440

    Google Scholar 

  • Gudelsky GA, Koenig JI, Meltzer HY (1986) Thermoregulatory responses to serotonin (5-HT) receptor stimulation in the rat. Neuropharmacology 25:1307–1313

    Google Scholar 

  • Hall H, Ogren SO (1981) Effects of antidepressant drugs on different receptors in the brain. Eur J Pharmacol 70:393–407

    Google Scholar 

  • Hamon M, Cossery JM, Spampinato V, Gozlan H (1986) Are there selective ligands for 5-HT1A and 5-HT1B receptor binding sites in brain. TIPS 7:336–338

    Google Scholar 

  • Hjorth S (1985) Hypothermia in the rat induced by the potent serotonergic agent 8-OH-DPAT. J Neural Transm 61:131–135

    Google Scholar 

  • Hjorth S, Carlsson A (1986) Is pindolol a mixed agonist-antagonist at central serotonin receptors? Eur J Pharmacol 129:131–138

    Google Scholar 

  • Invernizzi R, Cotecchia S, DeBlasi A, Mennini T, Pataccini R, Samanin R (1981) Effects of m-chlorophenylpiperazine on receptor binding and brain metabolism of monoamines in rats. Neurochem Int 3:239–244

    Google Scholar 

  • Kalkman HO, Timmermans PSMWM, Van Zwieten PA (1982) Characterization of the antihypertensive properties of ketanserin (R 41 468) in rats. J Pharmacol Exp Ther 222:227–231

    Google Scholar 

  • Kendall DA, Nahorski SR (1984) Suppression of 5-HT receptor mediated inositol phospholipid breakdown in brain by chronic antidepressant treatment. Br J Pharmacol 82:206P

    Google Scholar 

  • Kendall DA, Duman R, Slopis J, Enna SJ (1982) Influence of adrenocorticotrophin hormone and yohimbine on antidepressant-induced declines in rat brain neurotransmitter receptor binding and function. J Pharmacol Exp Ther 22:566–571

    Google Scholar 

  • Knoll J (1976) Analysis of the pharmacological aspects of selective monoamine oxidase inhibitors. In: Wolstenholme GEW, Knight J (eds) Monoamine oxidase and its inhibition. Elsevier, Amsterdam, pp 135–161

    Google Scholar 

  • Kruk ZL (1972) The effect of drugs acting on dopamine receptors on the body temperature of the rat. Life Sci 11:845–850

    Google Scholar 

  • Leysen J (1984) Problems in in vitro receptor binding studies and identification and role of serotonin receptor sites. Neuropharmacology 23:247–254

    Google Scholar 

  • Leysen JE, Awouters F, Kennis L, Laduron PM, Vandenberk J, Janssen PA (1981) Receptor binding profile of R41-468 a novel antagonist at 5-HT2 receptors. Life Sci 28:1015–1022

    Google Scholar 

  • Leysen JE, Gommeren W, Van Gompel P, Wynants J, Janssen PFM, Laduron PM (1985) Receptor-binding properties in vitro and in vivo of ritanserin: a very potent and long acting serotonin-S2 antagonist. Mol Pharmacol 27:600–611

    Google Scholar 

  • Lucki I, Frazer A (1982) Prevention of the serotonin syndrome in rats by repeated administration of monoamine oxidase inhibitors but not tricyclic antidepressants. Psychopharmacology 77:205–211

    Google Scholar 

  • Maggi A, U'Prichard DC, Enna SJ (1980) Differential effects of antidepressant treatment on brain monoaminergic receptors. Eur J Pharmacol 61:91–98

    Google Scholar 

  • Maj J, Lewandowska A (1980) Central serotoninmimetic action of phenylpiperazine. Pol J Pharmacol Pharm 32:495–504

    Google Scholar 

  • Martin LL, Sanders-Bush E (1982) Comparison of the pharmacological characteristics of 5-HT1 and 5-HT2 binding sites with those of serotonin autoreceptors which modulate serotonin release. Naunyn Schmiedeberg's Arch Pharmacol 321:165–170

    Google Scholar 

  • Mawson C, Whittington H (1970) Evaluation of the peripheral and central antagonistic activities against 5-hydroxytryptamine of some new agents. Br J Pharmacol 39:223P

    Google Scholar 

  • Meltzer HY, Simonovic M, Gudelsky GA (1983) Effects of pirenperone and ketanserin on rat prolactin secretion in vivo and in vitro. Eur J Pharmacol 92:83–89

    Google Scholar 

  • Melzacka M, Boksa J, Maj J (1979) 1-(m-Chlorophenyl)piperazine: a metabolite of trazodone isolated from rat urine. J Pharm Pharmacol 31:855–856

    Google Scholar 

  • Mueller EA, Sunderland T, Murphy DL (1985) Neuroendocrine effects of m-CPP, a serotonin agonist, in humans. J Clin Endocrinol Metab 61:1179–1184

    Google Scholar 

  • Mueller EA, Murphy DL, Sunderland T (1986) Further studies of the putative serotonin agonist, m-chlorophenylpiperazine: evidence for a serotonin receptor mediated mechanism of action in humans. Psychopharmacology 89:388–391

    Google Scholar 

  • Ogren SO, Fuxe K, Agnati LF, Gustafsson JA, Jonsson G, Holm AC (1979) Reevaluation of the indoleamine hypothesis of depression. Evidence for a reduction of functional activity of central 5-HT systems by antidepressant drugs. J Neural Transm 46:85–103

    Google Scholar 

  • Olpe HR (1981) Differential effect of chlorimipramine and clorgyline on the sensitivity of cortical neurons to serotonin. Eur J Pharmacol 69:375–377

    Google Scholar 

  • Pawlowski L (1984) Amitriptyline and femoxetine, but not clomipramine or citalopram, antagonize hyperthermia induced by directly acting 5-hydroxytryptamine-like drugs in heat adapted rats. J Pharm Pharmacol 36:197–199

    Google Scholar 

  • Persson B, Hedner T, Henning M (1982) Cardiovascular effects in the rat of ketanserin, a novel 5-hydroxytryptamine receptor blocking agent. J Pharm Pharmacol 34:442–445

    Google Scholar 

  • Peroutka SJ, Snyder SH (1980) Long term antidepressant treatment decreases spiroperidol-labelled serotonin receptor binding. Science 210:88–90

    Google Scholar 

  • Pettibone DJ, Williams M (1984) Serotonin-releasing effects of substituted piperazines in vitro. Biochem Pharmacol 33:1531–1535

    Google Scholar 

  • Quattrone A, Schettini G, Annunziato L, Di Renzo G (1981) Pharmacological evidence of supersensitivity of central serotonergic receptors involved in the control of prolactin secretion. Eur J Pharmacol 76:9–13

    Google Scholar 

  • Rowan MJ, Anwyl R (1985) The effect of prolonged treatment with tricyclic antidepressants on the actions of 5-hydroxytryptamine in the hippocampal slice of the rat. Neuropharmacology 24:131–137

    Google Scholar 

  • Samanin R, Mennini T, Ferraris A, Bendotti C, Borsini F, Garattini S (1979) m-Chlorophenylpiperazine: a central serotonin agonist causing powerful anorexia in rats. Naunyn-Schmiedeberg's Arch Pharmacol 308:159–163

    Google Scholar 

  • Samanin R, Mennini T, Ferraris A, Bendotti C, Borsini F (1980) Hyper- and hyposensitivity of central serotonin receptors: 3H-serotonin binding and functional studies in the rat. Brain Res 189:449–457

    Google Scholar 

  • Savage DD, Mendels J, Frazer A (1980) Monoamine oxidase inhibitors and serotonin uptake inhibitors: differential effects on [3H]serotonin binding sites in rat brain. J Pharmacol Exp Ther 212:259–263

    Google Scholar 

  • Segawa T, Mizuta T, Nomura Y (1979) Modifications of central 5-hydroxytryptamine binding sites in synaptic membranes from rat brain after long-term administration of tricyclic antidepressants. Eur J Pharmacol 58:75–83

    Google Scholar 

  • Sills MA, Wolfe BB, Frazer A (1984) Determination of selective and non-selective compounds for the 5-HT1A and 5-HT1B receptor subtypes in rat frontal cortex. J Pharmacol Exp Ther 231:480–487

    Google Scholar 

  • Stolz JF, Marsden CA, Middlemiss DN (1983) Effect of chronic antidepressant treatment and subsequent withdrawal on [3H]-5-hydroxytryptamine and [3H]-spiperone binding in rat frontal cortex and serotonin receptor mediated behaviour. Psychopharmacology 80:150–155

    Google Scholar 

  • Tang SW, Seeman P (1980) Effect of antidepressant drugs on serotonergic and adrenergic receptors. Naunyn-Schmiedeberg's Arch Pharmacol 311:255–261

    Google Scholar 

  • Willner P (1985) Antidepressant and serotonergic neurotransmission: an integrative review. Psychopharmacology 85:387–404

    Google Scholar 

  • Wozniak KM, Aulakh CS, Hill JL, Murphy DL (1988) The effect of 8-OH-DPAT on temperature in the rat and its modification by chronic antidepressant treatments. Pharmacol Biochem Behav 30:451–456

    Google Scholar 

  • Yang H-Y, Neff NH (1974) The monoamine oxidases of brain: selective inhibition with drugs and the consequence for the metabolism of the biogenic amines. J Pharmacol Exp Ther 189:733–740

    Google Scholar 

  • Zohar J, Insel TR, Zohar-Kadouch RC, Hill JL, Murphy DL (1988) Serotonergic responsivity in obsessive-compulsive disorder: effects of chronic clomipramine treatment. Arch Gen Psychiatry 45:167–172

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wozniak, K.M., Aulakh, C.S., Hill, J.L. et al. Hyperthermia induced by m-CPP in the rat and its modification by antidepressant treatments. Psychopharmacology 97, 269–274 (1989). https://doi.org/10.1007/BF00442262

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00442262

Key words

Navigation